The Biden plan released this week is an update of the Affordable Care Act with controversial differences. Among them: a “public option” that covers abortion, and subsidized premiums for more people.
Provisional overdose data for 2018 show a note of hope in an overall bleak picture. But in some states, the numbers actually got worse. What explains the disparities?
NPR’s Mary Louise Kelly talks with Washington Post reporter Scott Higham about federal data that shows the scope of the opioid crisis: 76 billion pills distributed between 2006 through 2012.
Trump administration officials say drugs’ list prices are like cars’ sticker prices — easily negotiated. But in the life and death world of medicine, health economists say, that analogy falls apart.
The first civil trial against an opioid manufacturer, Johnson & Johnson, has ended in Oklahoma. The verdict could affect lawsuits filed by other local and state governments coping with addiction.
Sepsis, the body’s overreaction to infection, strikes more than a million Americans a year and kills more than 250,000. Evidence suggests that regulations can improve its diagnosis and patient care.
The federal government wants to deploy several new tools for catching insurers that have overcharged Medicare $30 billion in last three years alone. But the insurance industry is balking.
Monday was the last day in a widely-watched trial about opioid addiction in Oklahoma. The state sued opioid manufacturers, but only Johnson & Johnson fought it in court after others settled.
Some physicians say connecting environmental effects of climate change — heat waves, more pollen and longer allergy seasons — to the health consequences helps them better care for patients.
This week, President Trump signed an executive order aimed at improving the care of kidney patients. Nephrologist Amaka Eneanya talks with Scott Simon about some of the new initiatives.